Didier Guillemot

Author PubWeight™ 54.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Modest public health impact of nontargeted human immunodeficiency virus screening in 29 emergency departments. Arch Intern Med 2011 4.03
2 Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 2009 2.70
3 Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis 2003 2.19
4 Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol 2009 2.03
5 National campaigns to improve antibiotic use. Eur J Clin Pharmacol 2006 1.84
6 Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol 2005 1.83
7 Major role for amphotericin B-flucytosine combination in severe cryptococcosis. PLoS One 2008 1.43
8 Troublesome heterotopic ossification after central nervous system damage: a survey of 570 surgeries. PLoS One 2011 1.37
9 Peripatetic health-care workers as potential superspreaders. Proc Natl Acad Sci U S A 2009 1.37
10 Antibacterial resistance, Wayampis Amerindians, French Guyana. Emerg Infect Dis 2004 1.30
11 S. pneumoniae transmission according to inclusion in conjugate vaccines: Bayesian analysis of a longitudinal follow-up in schools. BMC Infect Dis 2006 1.23
12 Imported episodic rabies increases patient demand for and physician delivery of antirabies prophylaxis. PLoS Negl Trop Dis 2010 1.17
13 Emergence and dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population. J Infect Dis 2010 1.16
14 Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations. Hum Vaccin 2009 1.14
15 Organic and conventional fruits and vegetables contain equivalent counts of Gram-negative bacteria expressing resistance to antibacterial agents. Environ Microbiol 2009 1.08
16 Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France. Antimicrob Agents Chemother 2011 1.07
17 Spread of a Klebsiella pneumoniae strain producing a plasmid-mediated ACC-1 AmpC beta-lactamase in a teaching hospital admitting disabled patients. Antimicrob Agents Chemother 2005 1.04
18 Contribution of mathematical modeling to the fight against bacterial antibiotic resistance. Curr Opin Infect Dis 2011 1.01
19 Impact of antibiotic exposure patterns on selection of community-associated methicillin-resistant Staphylococcus aureus in hospital settings. Antimicrob Agents Chemother 2011 0.97
20 Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population. PLoS One 2008 0.95
21 Characteristics of human intestinal Escherichia coli with changing environments. Environ Microbiol 2008 0.93
22 Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. J Cyst Fibros 2012 0.93
23 Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units. J Antimicrob Chemother 2012 0.92
24 Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis. Pediatr Pulmonol 2009 0.89
25 Benchmarking the burden of 100 diseases: results of a nationwide representative survey within general practices. BMJ Open 2011 0.88
26 Is exposure to mercury a driving force for the carriage of antibiotic resistance genes? J Med Microbiol 2010 0.88
27 Diagnostic criteria of urinary tract infection in male patients with spinal cord injury. Neurorehabil Neural Repair 2010 0.87
28 No significant decrease in antibiotic use from 1992 to 2000, in the French community. J Antimicrob Chemother 2004 0.86
29 Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients. Eur Respir J 2012 0.86
30 Intrinsic epidemicity of Streptococcus pneumoniae depends on strain serotype and antibiotic susceptibility pattern. Antimicrob Agents Chemother 2011 0.86
31 Comparing human papillomavirus prevalences in women with normal cytology or invasive cervical cancer to rank genotypes according to their oncogenic potential: a meta-analysis of observational studies. BMC Infect Dis 2013 0.86
32 Measurement of immunoglobulin G against Mycobacterial antigen A60 in patients with cystic fibrosis and lung infection due to Mycobacterium abscessus. Clin Infect Dis 2004 0.85
33 Exploring individual HPV coinfections is essential to predict HPV-vaccination impact on genotype distribution: a model-based approach. Vaccine 2012 0.84
34 Identifying more epidemic clones during a hospital outbreak of multidrug-resistant Acinetobacter baumannii. PLoS One 2012 0.83
35 Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides. PLoS One 2008 0.83
36 Who seeks primary care for sleep, anxiety and depressive disorders from physicians prescribing homeopathic and other complementary medicine? Results from the EPI3 population survey. BMJ Open 2012 0.83
37 Did media attention of the 2009 A(H1N1) influenza epidemic increase outpatient antibiotic use in France?: A time-series analysis. PLoS One 2013 0.81
38 Impact of physician preferences for homeopathic or conventional medicines on patients with musculoskeletal disorders: results from the EPI3-MSD cohort. Pharmacoepidemiol Drug Saf 2012 0.81
39 Outpatient antibiotic use in France between 2000 and 2010: after the nationwide campaign, it is time to focus on the elderly. Antimicrob Agents Chemother 2013 0.80
40 Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models. Proc Biol Sci 2013 0.80
41 Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamics. Antimicrob Agents Chemother 2010 0.80
42 Consequences of bacterial resistance to antimicrobial agents. Emerg Infect Dis 2004 0.80
43 Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France. BMC Musculoskelet Disord 2011 0.80
44 Pneumococcal resistance in the postvaccine era. Pediatr Infect Dis J 2006 0.79
45 HPV genotype replacement: too early to tell. Lancet Infect Dis 2013 0.78
46 Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2013 0.78
47 Benchmarking clinical management of spinal and non-spinal disorders using quality of life: results from the EPI3-LASER survey in primary care. Eur Spine J 2011 0.78
48 Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward. BMC Infect Dis 2013 0.77
49 Antibiotics for nasopharyngitis are associated with a lower risk of office-based physician visit for acute otitis media within 14 days for 3- to 6-year-old children. J Eval Clin Pract 2008 0.76
50 A pharmaco-epidemiological analysis of factors associated with antimicrobial consumption level in turkey broiler flocks. Vet Res 2005 0.76
51 [Infectious diseases risk management]. Rev Prat 2005 0.75
52 Testing independence between two Poisson-generated multinomial variables in case-series and cohort studies. Stat Med 2005 0.75
53 Mathematical models of infection transmission in healthcare settings: recent advances from the use of network structured data. Curr Opin Infect Dis 2017 0.75
54 [Avoidable hospital drug prescription in the elderly. A review of the literature]. Ann Med Interne (Paris) 2002 0.75
55 Any impact of bacterial resistance on antibiotic use in the community? Int J Med Microbiol 2002 0.75
56 Characterizing and Comparing the Seasonality of Influenza-Like Illnesses and Invasive Pneumococcal Diseases Using Seasonal Waveforms. Am J Epidemiol 2017 0.75
57 Vaccines: specific features, simulation of impact and medico-economic modelling. Therapie 2010 0.75